Established in 2021, #HERA has been at the centre of reinforcing EU readiness for medical countermeasures. Almost four years on, the European Commission’s review has triggered a reflection on how to strengthen HERA’s institutional design and operation in the years to come. At this pivotal moment, we are organising a roundtable to present two new research reports on: 🔹 Strengthening HERA’s leadership in preparing and responding to global health challenges. 🔹 Reinforcing stakeholder engagement through improved communication, transparency and responsiveness. Following the presentations, we will explore possible scenarios and reform pathways with a stellar panel: 🗣️ Dr. Florika Fink-Hooijer, Director General of HERA 🗣️ MEP Tomislav Sokol 🗣️ Sibilia Quilici, Executive Director of Vaccines Europe at EFPIA - European Federation of Pharmaceutical Industries and Associations 🗣️ Willo Brock, EU Representative at CEPI (Coalition for Epidemic Preparedness Innovations) Moderated by our Director of Research Andrea Renda JOIN THE DISCUSSION 👉 https://lnkd.in/dWeMppzX
